DrThomasCuisset(@CuissetDr) 's Twitter Profile Photo

2024 Major LBT – LANDMARK

Previous head-to-head comparisons of new THVs with established devices confirmed no class effect of clinical benefits after with inferior safety & efficacy for some of them.
Validation of MyVal non-inferiority to the most widely used

account_circle
Khaled AlShaibi(@drptca) 's Twitter Profile Photo

A fantastic way to deliver blended learning. Case based discussion, with educational points delivered through a combination of a smart screen, a silicone bench model combined with imaging by great facilitators MIЯVΛƬ #IC PCRonline 🫀

account_circle
Ivana Iveljic(@1blueivy) 's Twitter Profile Photo

At the 2024 I had a presentation in a session ‘PCI complications’ titled ‘Misbehaving stent’.
I am very proud to be the only interventional cardiologist from Bosnia and Herzegovina whose submitted work was elected to be presented in Paris.
PCRonline 🫀

account_circle
nicolas dumonteil(@nicolasdumonte1) 's Twitter Profile Photo

2024 Major LBTs: NOTION-2

This study provides further data concerning the 1-year outcome of younger AS patients with tricuspid valve anatomy treated with compared to SAVR. In this population, TAVI and SAVR showed similar rates of the primary endpoint at 1 year,

account_circle
SimHub(@SimHub_) 's Twitter Profile Photo

The largest ever is behind us!🥳
We are thrilled to have been involved in this amazing event!🦾
Let's summarize:
3⃣performances by A. Zlahoda-Huzior and A. Khokhar
1⃣ scientific poster 👇

Thank you all and see you next year! ✈️

account_circle
PCRonline 🫀(@PCRonline) 's Twitter Profile Photo

Can we use provisional stent strategy in complex lesions?

📺pcronline.com/Cases-resource…

Watch this session replay to gain valuable insights into the appropriate use of provisional stent strategies for complex bifurcation lesions, explore optimisation techniques for

Can we use   provisional stent strategy in complex #bifurcation lesions?

📺pcronline.com/Cases-resource…

Watch this session replay to gain valuable insights  into the appropriate use of provisional stent strategies for complex  bifurcation lesions, explore optimisation techniques for
account_circle
Wail AlkashkariFSCAI,FPICSوائل القشقرى🇸🇦🇨🇦🇺🇲(@AlkashkariWail) 's Twitter Profile Photo

صور من ترأسي لجلسه علميه عن صمامات القلب اليوم في مؤتمر ' EuroPCR 2024'..
الكثير من التقدم في تكنولوجيا عالم الصمامات القلبيه، اصبحت الصمامات بالقسطرة اكثر أمانا وفعاليه مقارنة بالسابق. ولكن لابد ان تعمل بالأيدي الخبيره والمتمرسه.

والله هو الشافي

صور من ترأسي لجلسه علميه عن صمامات القلب اليوم في مؤتمر ' EuroPCR 2024'.. 
الكثير من التقدم في تكنولوجيا عالم الصمامات القلبيه، اصبحت الصمامات بالقسطرة اكثر أمانا وفعاليه مقارنة بالسابق. ولكن لابد ان تعمل بالأيدي الخبيره والمتمرسه.

والله هو الشافي
account_circle
Italian Cardiologists Of Tomorrow(@italian_cot) 's Twitter Profile Photo

💡🧠 ICOT PRESENTA: MOST IMPACTFUL TRIALS FROM EUROPCR 2024 🧠

📌 LANDMARK Trial
📌 REC-CAGEFREE II Trial
📌 NOTION-2 Trial
📌 DESyne BDS Plus Study 12-month outcomes.
📌 IRONMAN-II Trial:
📌 BIO ASCEND ISR Trial:
📌 BIOADAPTOR RCT Study
📌 IDEAL-LM Trial, 5-year results.

💡🧠 ICOT PRESENTA: MOST IMPACTFUL TRIALS FROM EUROPCR 2024 🧠

📌 LANDMARK Trial
📌 REC-CAGEFREE II Trial
📌 NOTION-2 Trial
📌 DESyne BDS Plus Study 12-month outcomes.
📌 IRONMAN-II Trial: 
📌 BIO ASCEND ISR Trial: 
📌 BIOADAPTOR RCT Study
📌 IDEAL-LM Trial, 5-year results.
account_circle
DrThomasCuisset(@CuissetDr) 's Twitter Profile Photo

On behalf of the 2024 Course Directors, I want to extend our heartfelt thanks to each and every one of you for joining us at a truly global meeting in Paris. It was wonderful to have everyone come together for this significant event.

We recognize the commitment it takes

On behalf of the #EuroPCR 2024 Course Directors, I want to extend our heartfelt thanks to each and every one of you for joining us at a truly global meeting in Paris. It was wonderful to have everyone come together for this significant event.

We recognize the commitment it takes
account_circle
DrThomasCuisset(@CuissetDr) 's Twitter Profile Photo

Choosing from numerous interesting hotlines & LBTs at is tough, but here are my top picks: QFR for non-culprit lesion revascularization in elderly MI patients, residual TR post-transcatheter repair and its impact on survival, and LuxValvePlus system use for !

Choosing from numerous interesting hotlines & LBTs at #EuroPCR is tough, but here are my top picks: QFR for non-culprit lesion revascularization in elderly MI patients, residual TR post-transcatheter repair and its impact on survival, and LuxValvePlus system use for #TTVI!
account_circle
Davide Capodanno(@DFCapodanno) 's Twitter Profile Photo

A quick recap of new randomized trials in the fields of coronary and valvular interventions you may have missed this year at if you were only watching live cases or attending practical sessions.

account_circle
Profesor Dariusz Dudek - kardiolog(@PKardiolog) 's Twitter Profile Photo

Our team leads globally, showcasing a new era of optimized, low-contrast, and low-radiation procedures! 💡🔬 Proud to innovate for patient benefit worldwide! 🌍❤️

Our team leads globally, showcasing a new era of optimized, low-contrast, and low-radiation procedures! 💡🔬 Proud to innovate for patient benefit worldwide! 🌍❤️ #Cardiology #Innovation #EuroPCR #LessContrast #ModernMedicine
account_circle
Taishi Okuno(@taishiokuno) 's Twitter Profile Photo

明日です!

第一部はEuroPCRのLBTでも大活躍だったAtsushi Sugiura 先生のドイツのお話。

第二部では先日のSMART trialの結果も受けて、'狭小弁輪'という魔のキーワードについて再考します。
Tomoki Ochiai

明日です!

第一部はEuroPCRのLBTでも大活躍だった@AtsushiSssugi 先生のドイツのお話。

第二部では先日のSMART trialの結果も受けて、'狭小弁輪'という魔のキーワードについて再考します。
@TomokiOchiai
account_circle
Maurizio taramasso(@m_taramasso) 's Twitter Profile Photo

Shortcut IDE trial: safe, effective and reproducible. No learning curve! Is this technique going to be standard practice in all valve in valve?
PCRonline 🫀

Shortcut IDE trial: safe, effective and reproducible. No learning curve! Is this technique going to be standard practice in all valve in valve?
@PCRonline #tavi #europcr #lifetimemanagement
account_circle